Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.
Curr HIV/AIDS Rep
; 11(4): 393-403, 2014 Dec.
Article
en En
| MEDLINE
| ID: mdl-25283184
ABSTRACT
Treatment as prevention is expected to have a major role in reducing HIV incidence, but other prevention interventions will also be required to bring the epidemic under control, particularly among key populations. One or more forms of pre-exposure prophylaxis (PrEP) will likely play a critical role. Oral PrEP with emtricitabine-tenofovir (Truvada®) is currently available in the US and some other countries, but uptake has been slow. We review the concerns that have contributed to this slow uptake and discuss current and future research in this critical area of HIV prevention research.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Compuestos Organofosforados
/
Infecciones por VIH
/
Antirretrovirales
/
Desoxicitidina
/
Profilaxis Pre-Exposición
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
AIDS Rep
Asunto de la revista:
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Año:
2014
Tipo del documento:
Article